key: cord-0854405-77o9xb90
authors: El Hammoumi, Massine; Zegmout, Adil; Nya, Fouad; Bhairis, Mohamed; Kamdem, Marius; Kabiri, El Hassane
title: Huge thoracic tracheal tumor related to acute respiratory distress syndrome
date: 2021-10-05
journal: Kardiochir Torakochirurgia Pol
DOI: 10.5114/kitp.2021.109366
sha: ca98074ac7dce73d2246c5975cc305f74c647f0b
doc_id: 854405
cord_uid: 77o9xb90

nan

Adenoid cystic carcinoma of the trachea (ACCT) is an unusual low-grade tumor from the tracheal and bronchial wall salivary glands. ACCT occurs most commonly in the upper trachea, being found in the articular cartilage in the posterior part of the trachea.

We report the case of a patient with the rare condition of tracheal ACC who presented in an emergency condition that was successfully treated with a combination of surgery and radiotherapy.

Our patient was a 65-year-old, male, ex-smoker of 35 years. His condition began with mild dyspnea 2 years ago, with intense cough. With worsening of the aforementioned symptoms, he sought prompt care. In physical ex-amination the blood pressure was 110/65 mm Hg, arterial oxygenation (SaO 2 ) 86%. The probable diagnosis was a crisis of chronic obstructive pulmonary disease (COPD) or pulmonary embolism. After stabilizing the patient, injectable corticotherapy, enoxaparin and inhaled bronchodilators, a COVID-19 polymerase chain reaction (PCR) was negative. A C+ computed tomography (CT) of the chest showed an expansive lesion in the right wall of the thoracic trachea with an extension of approximately 3.1 cm, ending at the subcarinal level, measuring 4.5 × 2.8 cm, with a huge stenosis of the tracheal lumen, with an exophytic component to the mediastinum (Figures 1 A-C) . No specific COVID-19 related lesions were described. Bronchoscopy confirmed the ACCT exhibits slow growth and a low rate of local and distant metastasis. It is often clinically asymptomatic and the diagnosis is based on CT. Even with good imaging results for the characterization of the primary tumor and to document lymph nodal or distant metastases, the positron emission tomography-computed tomography (PET-CT) scan is also useful for staging and has been used for treatment. A better prognosis is mainly related to the feasibility of complete resection and to the absence of metastasis. However, symptoms such as wheezing, tracheitis, hemoptysis, and stridency are often unspecific and late. Lymph node involvement has not been associated with a worse progno-sis [1] [2] [3] [4] . The challenge is where the tracheal obstruction is major and respiratory distress syndrome occurs. Preoperative endoscopic disobstruction can remove life-threatening asphyxia but the tumor spread and complete resection related prognosis become out of control. The 5-year overall survival for tracheal ACC is approximately 30% with a reduction to less than 20% in cases of extratracheal extension. But with exclusive intraluminal disease, all the studies show a 5-year overall survival rate of 50% [5, 6] . The main treatment of ACC consists of radical surgical removal with Huge thoracic tracheal tumor related to acute respiratory distress syndrome negative margins achievement and reconstruction [5] [6] [7] [8] . Surgical techniques depend on the anatomic region. In cases of a standard resection in the distal trachea thoracotomy remain the optimal approach but sternotomy can be recommended when a carinal resection is probable; anastomosis is usually performed, though some practical limitations [2, 7] . Postoperative radiotherapy when complete resection cannot be achieved ensures a positive impact on survival [8] . ACC of the trachea, in fact, proved to be radiosensitive. There is no accepted standard in the dosage of postoperative radiotherapy, but usually it is 60 Gy (2 Gy per fraction, five fractions per week, for a total of 6 weeks). Palliative endotracheal brachytherapy in advanced stages with intent can also be used. Our patient experienced excellent disease control, with a good quality of life, and prolonged overall survival by combining surgery and radiotherapy.

In conclusion, due to the rarity of the disease related clinical trials, there is not yet a standardized therapeutic approach to tracheal ACC. In our case disease control could be achieved by complete removal surgery and adjuvant radiotherapy. Surgery is often scheduled can be a life saving emergency.

The authors report no conflict of interest.

Trachea: anatomy and pathology

Adenoid cystic carcinoma of the trachea: a report of seven cases and literature review

Adenoid cystic carcinoma of the airway: a 30-year review at one institution

Primary tracheal tumors: review of 37 cases

Adenoid cystic carcinoma of the trachea treated with PET-CT based intensity modulated radiotherapy

Primary adenoid cystic carcinoma of trachea presenting as midline neck swelling and mimicking thyroid tumor: a case report and review of literature

Adenoid cystic carcinoma of the upper trachea: a rare neoplasm

Adenoid cystic carcinoma of the airways: helical CT and histopathologic correlation